LIC announced on Thursday that it had sold 2 percent of its stake in Sun Pharma for Rs 4,699 crore in an open market transaction.
Following the share sale, there is a decrease of 2 percent decline in holding between July 22, 2022, and September 13, 2023.
In a regulatory filing, LIC stated, “Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 percent to 3.012 percent of the paid-up capital of the said company”.
“The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction”, LIC added.
Sun Pharma manufactures, develops, and markets a diverse range of branded and generic formulations, as well as Active Pharma Ingredients (APIs).
LIC, the country’s largest state-owned insurer, finished at Rs 660.80 per share on BSE, up 0.27 percent. Sun Pharma shares closed 0.8 percent higher at Rs 1,143.60.
Also read: Maruti Suzuki Collaborates With Indian Bank To Offer Dealers Financing Options
During Mann Ki Baat episode, PM Modi highlighted the Bodoland CEM Cup as a celebration…
India’s $900 billion retail sector, currently growing at 5%, is on the verge of accelerating…
India’s manufacturing sector is rapidly growing, driven by strong infrastructure and government policies, says Cushman…
India's sugar production is projected to grow by 15% in sugar season 2026 to 35…
India has made a historic leap in child immunisation by reducing the percentage of zero-dose…
India's auto sector powers economic growth with rising EV adoption, strong exports, and major policy…